Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.51 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30444224 | 1.00 | KDM4E (0.58) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL31307550 | 0.87 | KMT2A (0.51) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL9854041 | 0.87 | KMT2A (0.51) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL28110864 | 0.86 | RAB9A (0.60) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL28275103 | 0.86 | TSHR (0.50) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL19633270 | 0.85 | TSHR (0.53) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL5608478 | 0.84 | TSHR (0.58) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL1180585 | 0.84 | KDM4E (0.49) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL19675681 | 0.84 | KDM4E (0.50) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL1574197 | 0.83 | LOXL2 (0.51) | KDM4EMAPTALDH1A1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184520-A | Biphenyl amine compound, preparation method thereof and application thereof in flow battery | 中国科学院大连化学物理研究所 | 2024-06-14 | — | — | CN | claimed |
| EP-1786552-A1 | METHOD OF MAKING POLYMER MONOLITH COMPOSITE SUBSTRATE AND RESULTING SUBSTRATE AS WELL AS BEADS AND BEAD ARRAY | Applera Corporation (US) | 2007-05-23 | — | — | EP | claimed |
| WO-2006026378-A1 | METHOD OF MAKING POLYMER MONOLITH COMPOSITE SUBSTRATE AND RESULTING SUBSTRATE AS WELL AS BEADS AND BEAD ARRAY | APPLERA CORPORATION (US) | 2006-03-09 | — | — | WO | claimed |
| US-20260022099-A1 | ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF | NEXYS THERAPEUTICS, INC. (US) | 2026-01-22 | — | — | US | disclosed |
| US-12371408-B2 | Aryl hydrocarbon receptor agonists and uses thereof | NEXYS THERAPEUTICS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-12168646-B2 | Aryl hydrocarbon receptor agonists and uses thereof | NEXYS THERAPEUTICS, INC. (US) | 2024-12-17 | — | — | US | disclosed |
| EP-4472953-A1 | ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF | Nexys Therapeutics, Inc. (US) | 2024-12-11 | — | — | EP | disclosed |
| US-20240383868-A1 | SMARCA DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2024-11-21 | — | — | US | disclosed |
| US-20240326503-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2024-10-03 | — | — | US | disclosed |
| EP-4438300-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND | FUJIFILM Corporation (JP) | 2024-10-02 | — | — | EP | disclosed |
| CN-118722043-A | On-press development type lithographic printing plate precursor, method for producing lithographic printing plate, lithographic printing method, and compound | 富士胶片株式会社 | 2024-10-01 | — | — | CN | disclosed |
| EP-0652875-A1 | (HETERO)-ARYL KETONES DERIVATIVES WITH ANTIBACTERIAL PROPERTIES | SMITHKLINE BEECHAM PLC (GB) | 1995-05-17 | — | — | EP | disclosed |
| WO-1994002478-A1 | (HETERO)-ARYL KETONES DERIVATIVES WITH ANTIBACTERIAL PROPERTIES | SMITHKLINE BEECHAM PLC (GB) | 1994-02-03 | — | — | WO | disclosed |
| EP-0486749-A1 | Triarylmethane compounds and pressure sensitive recording material | HODOGAYA CHEMICAL CO., LTD. (JP) | 1992-05-27 | — | — | EP | disclosed |
| US-4535052-A | HIGH SPEED PHOTORESISTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-08-13 | — | — | US | disclosed |
| US-4506089-A | TREATMENT OF ISOMER MIXTURE WITH AN EMULSIFIER | BASF AKTIENGESELLSCHAFT (DE) | 1985-03-19 | — | — | US | disclosed |
| EP-0127762-A1 | Constrained N-alkylamino aryl ketones as sensitizers for photopolymer compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-12-12 | — | — | EP | disclosed |
| US-4133828-A | Manufacture of dimethylaminobenzenesulfonates | BASF AKTIENGESELLSCHAFT (DE) | 1979-01-09 | — | — | US | disclosed |
| US-4002664-A | Manufacture of dimethylaminobenzenecarboxylic acid esters | BASF AKTIENGESELLSCHAFT (DT) | 1977-01-11 | — | — | US | disclosed |
| US-3971821-A | Production of aminobenzaldehydes | BASF AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12371408-B2 | Aryl hydrocarbon receptor agonists and uses thereof | AHR, ARNT, NR1H2 | KDM4E 2343/4885MAPT 1282/4885ALDH1A1 602/4885 |
| US-20260022099-A1 | ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF | AHR, NR1H4, CNR1 | KDM4E 2121/4885MAPT 1624/4885ALDH1A1 807/4885 |
| US-20240383868-A1 | SMARCA DEGRADERS AND USES THEREOF | SMARCA1, SMARCA2, SMARCC2 | KDM4E 223/4885MAPT 3823/4885ALDH1A1 2230/4885 |
| US-12168646-B2 | Aryl hydrocarbon receptor agonists and uses thereof | AHR, ARNT, NR1H2 | KDM4E 2343/4885MAPT 1282/4885ALDH1A1 602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.